Literature DB >> 12008177

Comparison of effect of intensive lipid lowering with atorvastatin to less intensive lowering with lovastatin on C-reactive protein in patients with stable angina pectoris and inducible myocardial ischemia.

Scott Kinlay1, Tracy Timms, Maureen Clark, Carolina Karam, Tim Bilodeau, Paul M Ridker, Nader Rifai, William Carlson, Donald M Lloyd-Jones, Michael Johnstone, Joel Rubenstein, Sidney Alexander, John Orav, Peter H Stone.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12008177     DOI： 10.1016/s0002-9149(02)02306-8

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  8 in total

Review 1.  C-reactive protein and risk of cardiovascular disease: evidence and clinical application.

Authors:  Paul M Ridker; Shari S Bassuk; Peter P Toth
Journal:  Curr Atheroscler Rep       Date:  2003-09       Impact factor: 5.113

2.  Intensive statin therapy in acute coronary syndromes and stable coronary heart disease: a comparative meta-analysis of randomised controlled trials.

Authors:  Jonathan Afilalo; Agnieska A Majdan; Mark J Eisenberg
Journal:  Heart       Date:  2007-02-03       Impact factor: 5.994

Review 3.  New insights in the treatment of dyslipidemia: a focus on cardiovascular event reduction and the anti-atherosclerotic effects of atorvastatin.

Authors:  Peter P Toth
Journal:  Curr Atheroscler Rep       Date:  2005-09       Impact factor: 5.113

Review 4.  Effects of atorvastatin on the different phases of atherogenesis.

Authors:  Paolo Rubba
Journal:  Drugs       Date:  2007       Impact factor: 9.546

5.  Anti-inflammatory and morphologic effects of pitavastatin on carotid arteries and thoracic aorta evaluated by integrated backscatter trans-esophageal ultrasound and PET/CT: a prospective randomized comparative study with pravastatin (EPICENTRE study).

Authors:  Takatomo Watanabe; Masanori Kawasaki; Ryuhei Tanaka; Koji Ono; Nobuo Kako; Maki Saeki; Noriyuki Onishi; Maki Nagaya; Noriaki Sato; Hirotaka Miwa; Masazumi Arai; Toshiyuki Noda; Sachiro Watanabe; Shinya Minatoguchi
Journal:  Cardiovasc Ultrasound       Date:  2015-04-02       Impact factor: 2.062

6.  Comparison of anti-inflammatory effect of atorvastatin with rosuvastatin in patients of acute coronary syndrome.

Authors:  Sushant Khurana; Surabhi Gupta; HiraLal Bhalla; Shefali Nandwani; Varad Gupta
Journal:  J Pharmacol Pharmacother       Date:  2015 Jul-Sep

7.  A Comparison of Ezetimibe and Evolocumab for Atherogenic Lipid Reduction in Four Patient Populations: A Pooled Efficacy and Safety Analysis of Three Phase 3 Studies.

Authors:  Michael J Koren; Peter H Jones; Jennifer G Robinson; David Sullivan; Leslie Cho; Thomas Hucko; J Antonio G Lopez; Alex N Fleishman; Ransi Somaratne; Erik Stroes
Journal:  Cardiol Ther       Date:  2020-06-20

8.  The effect of aggressive versus conventional lipid-lowering therapy on markers of inflammatory and oxidative stress.

Authors:  Douwe J Mulder; Paul L van Haelst; Martgriet H Wobbes; Rijk O Gans; Felix Zijlstra; Johan F May; Andries J Smit; Jan Willem Cohen Tervaert; Jasper J van Doormaal
Journal:  Cardiovasc Drugs Ther       Date:  2007-03-07       Impact factor: 3.727
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.